Cargando…
Validation of a quantitative 12-multigene expression assay (Oncotype DX(®) Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression
PURPOSE: To evaluate the Recurrence Score(®) of the quantitative 12-multigene expression assay and to determine risk groups based on the continuous Recurrence Score(®) in Korean patients. METHOD: A total of 95 patients with pathological T3N0 tumors and mismatch repair-proficient tumors were enrolled...
Autores principales: | Jeong, Duck Hyoun, Kim, Woo Ram, Min, Byung Soh, Kim, Young Wan, Song, Mi Kyung, Kim, Nam Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689269/ https://www.ncbi.nlm.nih.gov/pubmed/26719709 http://dx.doi.org/10.2147/OTT.S95543 |
Ejemplares similares
-
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX(® )Colon Cancer Assay
por: Clark-Langone, Kim M, et al.
Publicado: (2010) -
Spotlight on the utility of the Oncotype DX(®) breast cancer assay
por: Siow, Zhen Rong, et al.
Publicado: (2018) -
Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit
por: Kim, Jinkyoung, et al.
Publicado: (2019) -
The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016) -
The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint
por: Xin, Ling, et al.
Publicado: (2017)